Evidence map›Paper›PMID 36873494›Full record

ArticleHeliyon2023

Chlorogenic acid rich in coffee pulp extract suppresses inflammatory status by inhibiting the p38, MAPK, and NF-κB pathways.

Atcharaporn Ontawong, Acharaporn Duangjai, Chutima S Vaddhanaphuti, Doungporn Amornlerdpison, Sirinat Pengnet, Natakorn Kamkaew

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Potential lipid-lowering effects ofFrontiers in nutrition · 2026
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. DietaryAnimals : an open access journal from MDPI · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Coffee as a Source of Antioxidants and an Elixir of Youth.Antioxidants (Basel, Switzerland) · 2025
    Review
  17. Review
  18. Phytochemical-richFrontiers in nutrition · 2025
    Article
  19. Review
  20. Coffee: Fuel for Your Day or Foe for Your Arteries.Antioxidants (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Atcharaporn OntawongDivision of Physiology, School of Medical Sciences, University of Phayao, Phayao, Thailand.
Acharaporn DuangjaiDivision of Physiology, School of Medical Sciences, University of Phayao, Phayao, Thailand.
Chutima S VaddhanaphutiFaculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Doungporn AmornlerdpisonCenter of Excellence in Agricultural Innovation for Graduate Entrepreneur, Maejo University, Chiang Mai, Thailand.
Sirinat PengnetDivision of Physiology, School of Medical Sciences, University of Phayao, Phayao, Thailand.
Natakorn KamkaewDivision of Physiology, School of Medical Sciences, University of Phayao, Phayao, Thailand.
University of Phayao · THChiang Mai University · THMaejo University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coffee pulp (CP) is a coffee byproduct that contains various active ingredients, namely, chlorogenic acid (CGA) and caffeine. These active compounds show several benefits, including antihyperlipidemia, antioxidants, and anti-inflammation. However, the anti-inflammatory properties of Coffea pulp extract (CPE) are unknown. This work determined the impact of CPE on lipopolysaccharide (LPS)-activated murine macrophage cells and the molecular mechanism behind this action. RAW 264.7 cells were exposed to varying doses of CPE with or without LPS. Inflammatory markers and their mechanism were studied. CPE therapy has been shown to suppress the synthesis of inflammatory cytokines and mediators, namely, tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), IL-1β, cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and nitric oxide (NO), as well as prostaglandin E2 (PGE

Indexed as

Anti-InflammatoryCaffeineChlorogenic acidCoffee pulp extractMAPK signalingNuclear factor-kappa B

Identifiers

PMID36873494
PMCPMC9982044
OpenAlexW4321378564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.